Catherine Vaillant

865 total citations
20 papers, 724 citations indexed

About

Catherine Vaillant is a scholar working on Molecular Biology, Experimental and Cognitive Psychology and Cognitive Neuroscience. According to data from OpenAlex, Catherine Vaillant has authored 20 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Experimental and Cognitive Psychology and 4 papers in Cognitive Neuroscience. Recurrent topics in Catherine Vaillant's work include Sleep and related disorders (5 papers), Hedgehog Signaling Pathway Studies (4 papers) and Sleep and Wakefulness Research (4 papers). Catherine Vaillant is often cited by papers focused on Sleep and related disorders (5 papers), Hedgehog Signaling Pathway Studies (4 papers) and Sleep and Wakefulness Research (4 papers). Catherine Vaillant collaborates with scholars based in Switzerland, France and United States. Catherine Vaillant's co-authors include Nicole Thomasset, Denis Monard, M. Didier‐Bazes, Marie‐Françoise Belin, Dominique Bagnard, Marion Lohrum, Andreas W. Püschel, Marie-Françoise Belin, Jürgen Bolz and Jian‐Quan Ni and has published in prestigious journals such as Nucleic Acids Research, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Catherine Vaillant

17 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Vaillant Switzerland 8 439 249 206 91 86 20 724
Arek Szklarczyk United States 9 301 0.7× 229 0.9× 264 1.3× 49 0.5× 80 0.9× 9 604
Jochen Kinter Switzerland 12 454 1.0× 171 0.7× 177 0.9× 39 0.4× 58 0.7× 21 895
Eliza Moreno Switzerland 9 192 0.4× 143 0.6× 123 0.6× 34 0.4× 36 0.4× 9 431
Miwa Washida Japan 12 467 1.1× 142 0.6× 102 0.5× 46 0.5× 203 2.4× 15 871
Mathew C. Easterday United States 7 457 1.0× 133 0.5× 87 0.4× 199 2.2× 92 1.1× 8 692
Marita Meins Switzerland 10 288 0.7× 146 0.6× 182 0.9× 33 0.4× 28 0.3× 10 620
Kei-ichiro Yasunaga Japan 10 272 0.6× 233 0.9× 59 0.3× 31 0.3× 39 0.5× 18 544
Robert G. Farrer United States 13 386 0.9× 285 1.1× 58 0.3× 130 1.4× 39 0.5× 26 947
Zhicheng Mo United States 9 479 1.1× 147 0.6× 59 0.3× 159 1.7× 113 1.3× 12 856
Koji Oishi Japan 9 607 1.4× 228 0.9× 144 0.7× 231 2.5× 150 1.7× 16 924

Countries citing papers authored by Catherine Vaillant

Since Specialization
Citations

This map shows the geographic impact of Catherine Vaillant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Vaillant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Vaillant more than expected).

Fields of papers citing papers by Catherine Vaillant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Vaillant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Vaillant. The network helps show where Catherine Vaillant may publish in the future.

Co-authorship network of co-authors of Catherine Vaillant

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Vaillant. A scholar is included among the top collaborators of Catherine Vaillant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Vaillant. Catherine Vaillant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Surivet, Jean‐Philippe, Melanie Keßler, Christopher Kohl, et al.. (2025). Discovery of IDOR-1117-1680, a dual orexin receptor antagonist with fast onset and short duration of action for the treatment of insomnia. Bioorganic & Medicinal Chemistry. 122. 118132–118132.
2.
Steiner, Michel A., Giorgio Bergamini, Emanuela Micioni Di Bonaventura, et al.. (2024). Evaluating the efficacy of the selective orexin 1 receptor antagonist nivasorexant in an animal model of binge‐eating disorder. International Journal of Eating Disorders. 57(7). 1418–1432. 4 indexed citations
3.
Surivet, Jean‐Philippe, Melanie Keßler, Catherine Vaillant, et al.. (2024). Discovery, synthesis and SAR of 2-acyl-1-biarylmethyl pyrazolidines, dual orexin receptor antagonists designed as fast and short-acting sleeping drugs. Bioorganic & Medicinal Chemistry. 112. 117892–117892. 3 indexed citations
4.
Vaillant, Catherine, et al.. (2022). POSC430 Unmet Needs for Insomnia Patients - Economic Burden in Europe. Value in Health. 25(1). S277–S277. 2 indexed citations
5.
Vaillant, Catherine, et al.. (2022). POSA349 Unmet Needs for Insomnia Patients - Humanistic Burden in Europe. Value in Health. 25(1). S217–S217. 4 indexed citations
6.
Vaillant, Catherine, et al.. (2022). Les multiples perspectives du service polyvalent d’aide et de soins à domicile. Soins. 67(864). 29–31.
7.
Vaillant, Catherine, et al.. (2021). 059 Daridorexant: A dual, equipotent, and insurmountable antagonist of both orexin-1 and orexin-2 receptors. SLEEP. 44(Supplement_2). A25–A25. 6 indexed citations
8.
Ariès, Philippe, et al.. (2016). Self-induced drug intoxication in baclofen: of the calm hypotonic coma in the status epilepticus. Annales de biologie clinique. 74(3). 348–352. 8 indexed citations
9.
Vaillant, Catherine, Paola Valdivieso, Sandro Nuciforo, et al.. (2015). Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma. PLoS ONE. 10(4). e0124870–e0124870. 22 indexed citations
10.
Vaillant, Catherine, et al.. (2010). Newly generated cells are increased in hippocampus of adult mice lacking a serine protease inhibitor. BMC Neuroscience. 11(1). 70–70. 6 indexed citations
11.
Vaillant, Catherine & Denis Monard. (2009). SHH Pathway and Cerebellar Development. The Cerebellum. 8(3). 291–301. 92 indexed citations
12.
Vaillant, Catherine, Odyssé Michos, Slobodanka Orolicki, et al.. (2007). Protease nexin 1 and its receptor LRP modulate SHH signalling during cerebellar development. Development. 134(9). 1745–1754. 25 indexed citations
13.
Lucia, Filomena De, Jian‐Quan Ni, Catherine Vaillant, & Fang-Lin Sun. (2005). HP1 modulates the transcription of cell-cycle regulators in Drosophila melanogaster. Nucleic Acids Research. 33(9). 2852–2858. 73 indexed citations
14.
Vaillant, Catherine. (2003). MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum. Molecular and Cellular Neuroscience. 24(2). 395–408. 119 indexed citations
15.
Vaillant, Catherine, et al.. (2003). [Nurse's role in the multidisciplinary consultation for pain].. PubMed. 30–1. 2 indexed citations
16.
Pierrat, Véronique & Catherine Vaillant. (2002). Impact à long terme des stimulations douloureuses de la période néonatale. MTP. Médecine thérapeutique pédiatrie. 5(2). 83–85.
17.
Bagnard, Dominique, Catherine Vaillant, Marion Lohrum, et al.. (2001). Semaphorin 3A–Vascular Endothelial Growth Factor-165 Balance Mediates Migration and Apoptosis of Neural Progenitor Cells by the Recruitment of Shared Receptor. Journal of Neuroscience. 21(10). 3332–3341. 187 indexed citations
18.
Vaillant, Catherine, et al.. (1999). Spatiotemporal Expression Patterns of Metalloproteinases and Their Inhibitors in the Postnatal Developing Rat Cerebellum. Journal of Neuroscience. 19(12). 4994–5004. 168 indexed citations
19.
Ceppa, Franck, et al.. (1998). Évaluation du dosage en phase homogène du cholestérol des HDL. Revue Française des Laboratoires. 1998(307). 55–58. 1 indexed citations
20.
Boudin, G, et al.. (1964). [STATUS EPILEPTICUS REVEALING AN ANTHRAX MENINGITIS. ANATOMO-CLINICAL STUDY].. PubMed. 115. 183–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026